SCHEMBL4019997

SCHEMBL4019997

CCN1C(=CC=O)C(C)(C)c2cc(OC)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.40
HTT P42858 4/20 0.40
ALDH1A1 P00352 6/20 0.38
HPGD P15428 4/20 0.38
KDM4E B2RXH2 4/20 0.38
GLA P06280 1/20 0.38
HIF1A Q16665 1/20 0.38
MAPT P10636 6/20 0.38
KMT2A Q03164 6/20 0.38
NPSR1 Q6W5P4 5/20 0.38
MEN1 O00255 5/20 0.38
HSD17B10 Q99714 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
PIM1 P11309 2/20 0.38
CSNK1D P48730 2/20 0.38
CSNK1E P49674 2/20 0.38
CLK1 P49759 2/20 0.38
CLK3 P49761 2/20 0.38
CSNK1G2 P78368 2/20 0.38
DYRK1A Q13627 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4019995 1.00 LMNA (0.40) LMNAHTTALDH1A1HPGDKDM4E
SCHEMBL13657797 0.87 NPSR1 (0.36) LMNAHTTALDH1A1HPGDKDM4E
SCHEMBL11848116 0.82 HTT (0.60) LMNAHTTALDH1A1HPGDKDM4E
SCHEMBL11848108 0.82 HTT (0.60) LMNAHTTALDH1A1HPGDKDM4E
SCHEMBL4016802 0.81 PTGDR2 (0.40) LMNAHTTALDH1A1HPGDKDM4E
SCHEMBL4016799 0.81 PTGDR2 (0.40) LMNAHTTALDH1A1HPGDKDM4E
SCHEMBL4020020 0.78 MAPT (0.37) LMNAHTTALDH1A1HPGDMAPT
SCHEMBL4020017 0.78 MAPT (0.37) LMNAHTTALDH1A1HPGDMAPT
SCHEMBL11853161 0.77 HTT (0.65) LMNAHTTALDH1A1KDM4EGLA
SCHEMBL13966066 0.77 HTT (0.65) LMNAHTTALDH1A1KDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090252013-A1 HYDRAZIDE CHELATE COMPLEX COMPOUND, OPTICAL RECORDING MEDIUM USING THE COMPOUND AND RECORDING METHOD THEREOF MITSUBISHI CHEMICAL CORPORATION (JP) 2009-10-08 US disclosed
EP-2050794-A1 HYDRAZIDE CHELATE COMPLEX COMPOUND, OPTICAL RECORDING MEDIUM USING THE COMPOUND AND RECORDING METHOD THEREOF Mitsubishi Chemical Corporation (JP) 2009-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090252013-A1 HYDRAZIDE CHELATE COMPLEX COMPOUND, OPTICAL RECORDING MEDIUM USING THE COMPOUND AND RECORDING METHOD THEREOF KCNN2, KCNH2, KCNN1 LMNA 1854/4885HTT 1167/4885ALDH1A1 1012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.